Journal articles on the topic 'Generation of negative triples'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Generation of negative triples.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Vallée-Tourangeau, Frédéric, Neville G. Austin, and Sandra Rankin. "Inducing a Rule in Wason's 2–4–6 Task: A Test of the Information-Quantity and Goal-Complementarity Hypotheses." Quarterly Journal of Experimental Psychology Section A 48, no. 4 (November 1995): 895–914. http://dx.doi.org/10.1080/14640749508401422.
Vallée-Tourangeau, Frédéric. "Utilities in the 2-4-6 Task." Experimental Psychology 59, no. 5 (May 1, 2012): 265–71. http://dx.doi.org/10.1027/1618-3169/a000152.
Wang, Liuquan. "Arithmetic identities and congruences for partition triples with 3-cores." International Journal of Number Theory 12, no. 04 (April 10, 2016): 995–1010. http://dx.doi.org/10.1142/s1793042116500627.
Tierno, Domenico, Gabriele Grassi, Serena Scomersi, Marina Bortul, Daniele Generali, Fabrizio Zanconati, and Bruna Scaggiante. "Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications." International Journal of Molecular Sciences 24, no. 11 (June 2, 2023): 9688. http://dx.doi.org/10.3390/ijms24119688.
Wu, Jiande, Tarun K. K. Mamidi, Lu Zhang, and Chindo Hicks. "Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer." International Journal of Genomics 2020 (July 7, 2020): 1–16. http://dx.doi.org/10.1155/2020/2641370.
Lin, Po‐Han, Ming Chen, Li‐Wei Tsai, Chiao Lo, Tzu‐Chun Yen, Thomas Yoyan Huang, Chih‐Kai Chen, Sheng‐Chih Fan, Sung‐Hsin Kuo, and Chiun‐Sheng Huang. "Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer." Cancer Science 111, no. 4 (February 19, 2020): 1375–84. http://dx.doi.org/10.1111/cas.14313.
Wu, Jiande, Tarun Karthik Kumar Mamidi, Lu Zhang, and Chindo Hicks. "Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer." Cancers 12, no. 6 (June 12, 2020): 1559. http://dx.doi.org/10.3390/cancers12061559.
Raftery, Martin J., Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens-Uwe Blohmer, and Gabriele Pecher. "Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer." International Journal of Molecular Sciences 24, no. 10 (May 20, 2023): 9038. http://dx.doi.org/10.3390/ijms24109038.
Zhang, Zhenghang, Jinlu Jia, Yalin Wan, Yang Zhou, Yuting Kong, Yurong Qian, and Jun Long. "TransR*: Representation learning model by flexible translation and relation matrix projection." Journal of Intelligent & Fuzzy Systems 40, no. 5 (April 22, 2021): 10251–59. http://dx.doi.org/10.3233/jifs-202177.
Ben-Baruch, Noa, Tamar Peretz-Yablonski, Georgeta Fried, Moshe J. Inbar, Yousef Samih, Victoria Neiman, Bella Nisenbaum, et al. "Next-generation sequencing (NGS) in relapsed/refractory triple-negative breast cancer (TNBC) in Israel." Journal of Clinical Oncology 32, no. 15_suppl (May 20, 2014): 1028. http://dx.doi.org/10.1200/jco.2014.32.15_suppl.1028.
Thouvenot, B., S. Verdun, J. Tomasina, B. Hilselberger, M. Brulliard, L. Bonnard, M. Trarbach, J. Armand, V. Ogier, and B. E. Bihain. "P272 Using next-generation sequencing to predict clinical outcome of triple negative breast cancer." Breast 24 (March 2015): S120. http://dx.doi.org/10.1016/s0960-9776(15)70304-8.
Elsayed, Islam, and Yoshiki Nishi. "A Feasibility Study on Power Generation from Solar Thermal Wind Tower: Inclusive Impact Assessment Concerning Environmental and Economic Costs." Energies 11, no. 11 (November 16, 2018): 3181. http://dx.doi.org/10.3390/en11113181.
Caiazza, Francesco, Alyson Murray, Stephen F. Madden, Naoise C. Synnott, Elizabeth J. Ryan, Norma O’Donovan, John Crown, and Michael J. Duffy. "Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells." Endocrine-Related Cancer 23, no. 4 (April 2016): 323–34. http://dx.doi.org/10.1530/erc-16-0068.
Lips, Esther H., Magali Michaut, Lennart Mulder, Nicolle Besselink, Marlous L. Hoogstraat, Marco J. Koudijs, Emile E. Voest, et al. "Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC)." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 1010. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1010.
Hu, Zhiwei, Rulong Shen, Amanda Campbell, Elizabeth McMichael, Lianbo Yu, Bhuvaneswari Ramaswamy, Cheryl A. London, Tian Xu, and William E. Carson. "Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON." Cancer Immunology Research 6, no. 6 (April 5, 2018): 671–84. http://dx.doi.org/10.1158/2326-6066.cir-17-0343.
Wang, Wei, Hao Chen, Yang Xie, Sayantap Datta, Wei Li, and Ruiwen Zhang. "Abstract 678: Experimental therapy of triple negative breast cancer with next-generation of MDM2 inhibitors." Cancer Research 84, no. 6_Supplement (March 22, 2024): 678. http://dx.doi.org/10.1158/1538-7445.am2024-678.
Denu, Ryan A., Cissimol P. Joseph, Elizabeth S. Urquiola, Precious S. Byrd, Richard K. Yang, Ravin Ratan, Maria Alejandra Zarzour, et al. "Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors." Cancers 16, no. 9 (April 27, 2024): 1707. http://dx.doi.org/10.3390/cancers16091707.
Kareev, Yaakov, Naftali Halberstadt, and Dorit Shafir. "Improving Performance and Increasing the Use of Non-Positive Testing in a Rule-Discovery Task." Quarterly Journal of Experimental Psychology Section A 46, no. 4 (November 1993): 729–42. http://dx.doi.org/10.1080/14640749308401036.
Hossain, Fokhrul, Samarpan Majumder, Justin David, and Lucio Miele. "Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions." Cancers 13, no. 15 (July 26, 2021): 3739. http://dx.doi.org/10.3390/cancers13153739.
Alewine, Christine, Laiman Xiang, Takao Yamori, Gerhard Niederfellner, Klaus Bosslet, and Ira Pastan. "Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers." Molecular Cancer Therapeutics 13, no. 11 (September 19, 2014): 2653–61. http://dx.doi.org/10.1158/1535-7163.mct-14-0132.
Zhu, X., J. Bayani, M. Dewan, H. Tovey, L. Kilburn, K. Taylor, J. Banerji, et al. "307P Identifying new biological subgroups of triple-negative breast cancer using next-generation integrative clustering pipeline." Annals of Oncology 34 (October 2023): S306—S307. http://dx.doi.org/10.1016/j.annonc.2023.09.503.
Bhattarai, Shristi, Geetanjali Saini, Hongxiao Li, Gaurav Seth, Timothy B. Fisher, Emiel A. M. Janssen, Umay Kiraz, Jun Kong, and Ritu Aneja. "Predicting Neoadjuvant Treatment Response in Triple-Negative Breast Cancer Using Machine Learning." Diagnostics 14, no. 1 (December 28, 2023): 74. http://dx.doi.org/10.3390/diagnostics14010074.
Khandelwal, Soni, Mallory Boylan, Gilbert Kirsch, Julian E. Spallholz, and Lauren S. Gollahon. "Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer." Antioxidants 9, no. 2 (February 5, 2020): 138. http://dx.doi.org/10.3390/antiox9020138.
Pircher, Magdalena, Thomas Winder, and Andreas Trojan. "Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported Outcome." Case Reports in Oncology 14, no. 1 (March 29, 2021): 616–21. http://dx.doi.org/10.1159/000513905.
Herrera Juarez, Mercedes, Pablo Tolosa Ortega, Ana Sanchez de Torre, and Eva Ciruelos Gil. "Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features." Breast Care 15, no. 3 (2020): 208–16. http://dx.doi.org/10.1159/000508758.
Desa, Danielle E., Wencheng Wu, Robert M. Brown, Edward B. Brown, Robert L. Hill, Bradley M. Turner, and Edward B. Brown. "Second-Harmonic Generation Imaging Reveals Changes in Breast Tumor Collagen Induced by Neoadjuvant Chemotherapy." Cancers 14, no. 4 (February 9, 2022): 857. http://dx.doi.org/10.3390/cancers14040857.
Yang, Biyao, Rui Sang, Yi Li, Ewa Goldys, and Wei Deng. "Abstract 5743: Liposome platform enables X-ray induced photodynamic therapy treatment against human triple negative breast cancer cells." Cancer Research 84, no. 6_Supplement (March 22, 2024): 5743. http://dx.doi.org/10.1158/1538-7445.am2024-5743.
Nagahashi, Masayuki, Tetsu Hayashida, Yuko Kitagawa, Manabu Futamura, Kazuhiro Yoshida, Takashi Kuwayama, Seigo Nakamura, et al. "Comprehensive genomic sequencing for triple negative breast cancer in Japan." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e23122-e23122. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e23122.
Ashourpour, Maryam, Fatemeh Mostafavi Hosseini, Mohsen Amini, Ebrahim Saeedian Moghadam, Faranak Kazerouni, Seyed Yousef Arman, and Zahra Shahsavari. "Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468." Asian Pacific Journal of Cancer Prevention 22, no. 7 (July 1, 2021): 2079–87. http://dx.doi.org/10.31557/apjcp.2021.22.7.2079.
Weisman, Paul S., Charlotte K. Y. Ng, Edi Brogi, Rachel E. Eisenberg, Helen H. Won, Salvatore Piscuoglio, Maria R. De Filippo, et al. "Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology." Modern Pathology 29, no. 5 (March 4, 2016): 476–88. http://dx.doi.org/10.1038/modpathol.2016.39.
Sangiorgio, Valentina, Rocco Giovanni Piazza, Federica Mottadelli, Fabio Pagni, Inzoli Elena, Carlo Gambacorti-Passerini, Gianni Cazzaniga, and Elena Maria Elli. "P1056: NEXT GENERATION SEQUENCING IDENTIFIES SUBGROUPS OF PATIENTS WITH TRIPLE NEGATIVE/ PRIMARY THROMBOCYTOSIS WITH DIFFERENT CLINICAL OUTCOMES." HemaSphere 7 (August 2023): e7820571. http://dx.doi.org/10.1097/01.hs9.0000971120.78205.71.
Berisha, Eranda, Maria del Carmen Chacon Castro, Adnin Ashrafi, Narges Salamat, Parinaz Sadat Alemi, and Li Zhang. "Abstract 4942: Heme targeting and its mechanistic role in triple-negative breast cancer suppression." Cancer Research 83, no. 7_Supplement (April 4, 2023): 4942. http://dx.doi.org/10.1158/1538-7445.am2023-4942.
Yun, Jiwon, Jung-Ah Kim, Byungjin Hwang, Hee Sue Park, Kyongok Im, Sung-Min Kim, Dajeong Jeong, Kyu Min Lim, Duhee Bang, and Dong Soon Lee. "Triple-Negative Myeloproliferative Neoplasms Vs. Calr, JAK2 or MPL-Mutated Myeloproliferative Neoplasms: Distinct Molecular Characteristics." Blood 132, Supplement 1 (November 29, 2018): 1772. http://dx.doi.org/10.1182/blood-2018-99-118013.
Morris, Lindsay Kaye, Matthew Stein, Saradasri Karri, Srishti Sareen, Kruti Patel, Gregory A. Vidal, Lee Steven Schwartzberg, and Michael Gary Martin. "Distribution of receptor tyrosine kinase (RTK) nsSNPs in breast cancer (BC) patients (pts) using next-generation sequencing (NGS)." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 1080. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1080.
Kalyane, Dnyaneshwar, Suryanarayana Polaka, Nupur Vasdev, and Rakesh Kumar Tekade. "CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells." Pharmaceutics 14, no. 12 (December 6, 2022): 2734. http://dx.doi.org/10.3390/pharmaceutics14122734.
Svidnicki, Maria Carolina Costa Melo, Paula De Melo Campos, Moisés Alves Ferreira Filho, Caio Augusto Leme Fujiura, Tetsuichi Yoshizato, Hideki Makishima, Seishi Ogawa, and Sara T. Olalla Saad. "Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms." Blood 134, Supplement_1 (November 13, 2019): 5395. http://dx.doi.org/10.1182/blood-2019-128764.
Dameri, Martina, Lorenzo Ferrando, Gabriella Cirmena, Claudio Vernieri, Giancarlo Pruneri, Alberto Ballestrero, and Gabriele Zoppoli. "Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer." International Journal of Molecular Sciences 22, no. 13 (July 1, 2021): 7154. http://dx.doi.org/10.3390/ijms22137154.
Bahman, Fatemah, Valeria Pittalà, Mohamed Haider, and Khaled Greish. "Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer." Journal of Personalized Medicine 11, no. 6 (June 15, 2021): 559. http://dx.doi.org/10.3390/jpm11060559.
He, W., Y. Zhang, Y. Deng, and D. Kabelitz. "Induction of TCR-gamma delta expression on triple-negative (CD3-4-8-) human thymocytes. Comparative analysis of the effects of IL-4 and IL-7." Journal of Immunology 154, no. 8 (April 15, 1995): 3726–31. http://dx.doi.org/10.4049/jimmunol.154.8.3726.
Bian, Yanlin, Tong Lin, Tanja Jakos, Xiaodong Xiao, and Jianwei Zhu. "The Generation of Dual-Targeting Fusion Protein PD-L1/CD47 for the Inhibition of Triple-Negative Breast Cancer." Biomedicines 10, no. 8 (July 30, 2022): 1843. http://dx.doi.org/10.3390/biomedicines10081843.
Wang, Nan, Kun Li, Wenfa Huang, Weiyao Kong, Xiaoran Liu, Weijie Shi, Feng Xie, et al. "Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing." Chinese Journal of Cancer Research 32, no. 2 (2020): 149–62. http://dx.doi.org/10.21147/j.issn.1000-9604.2020.02.03.
Huang, Xin, Huanwen M. Wu, Changbin Zhu, Di Shao, Dan Guo, Yidong Zhou, Yan Lin, et al. "Next generation sequencing reveals CCNE1 amplification as an independent prognostic factor for triple negative breast cancer (TNBC) patients." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 558. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.558.
Landers, Mark, Rhonda Meredith, Jerry Lee, Yipeng Wang, Byung-In Lee, and Joseph Monforte. "Next-generation sequencing mutational analysis of triple-negative breast cancer patients from matched FFPE and fresh frozen samples." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 1058. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1058.
Anders, Carey K., Vandana Abramson, Tira Tan, and Rebecca Dent. "The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics." American Society of Clinical Oncology Educational Book, no. 36 (May 2016): 34–42. http://dx.doi.org/10.1200/edbk_159135.
Khadela, Avinash, Vivek P. Chavda, Shruti Soni, Kaivalya Megha, Aanshi J. Pandya, and Lalitkumar Vora. "Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer." Cancers 15, no. 1 (December 30, 2022): 233. http://dx.doi.org/10.3390/cancers15010233.
Andreidesz, Kitti, Balazs Koszegi, Dominika Kovacs, Viola Bagone Vantus, Ferenc Gallyas, and Krisztina Kovacs. "Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells." International Journal of Molecular Sciences 22, no. 4 (February 19, 2021): 2056. http://dx.doi.org/10.3390/ijms22042056.
Shiau, Jun-Ping, Cheng-Che Wu, Shu-Jyuan Chang, Mei-Ren Pan, Wangta Liu, Fu Ou-Yang, Fang-Ming Chen, Ming-Feng Hou, Shen-Liang Shih, and Chi-Wen Luo. "FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer." Biomedicines 9, no. 12 (November 29, 2021): 1789. http://dx.doi.org/10.3390/biomedicines9121789.
Subhan, Md Abdus, Farzana Parveen, Hassan Shah, Satya Siva Kishan Yalamarty, Janaína Artem Ataide, and Valdimir P. Torchilin. "Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type." Cancers 15, no. 8 (April 8, 2023): 2204. http://dx.doi.org/10.3390/cancers15082204.
Jagadish, Nirmala, Sonika Devi, Namita Gupta, Vitusha Suri, and Anil Suri. "Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells in vitro and in vivo." Tumor Biology 42, no. 4 (April 2020): 101042832091447. http://dx.doi.org/10.1177/1010428320914477.
Mohammadhosseinpour, Sepideh, Alexx Weaver, Meenakshi Sudhakaran, Linh-Chi Ho, Tra Le, Andrea I. Doseff, and Fabricio Medina-Bolivar. "Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells." Cancers 15, no. 2 (January 7, 2023): 399. http://dx.doi.org/10.3390/cancers15020399.